COOKSON PEIRCE & CO INC

Position in NVS — Novartis AG

CIK 1141455 PITTSBURGH, PA

Position in NVS

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$43,322,496

+$6,243,325 QoQ

Shares Held

283,617

+5.5% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

1.94%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

COOKSON PEIRCE & CO INC holds $103,842,214 across 6 Drug Manufacturers - General names. NVS ranks #2 (41.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	61,609	$56,666,109
2	NVS	Novartis AG This page	283,617	$43,322,496
3	AZN	Astrazeneca PLC	8,635	$1,702,994
4	GILD	Gilead Sciences, Inc.	8,663	$1,207,362
5	BMY	Bristol Myers Squibb Co	9,519	$577,327
6	JNJ	Johnson & Johnson	1,497	$365,926

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$43,322,496	283,617	+5.5%	Shares	Sole	2026-04-30
2025-12-31	$37,079,171	268,943	-1.2%	Shares	Sole	2026-02-11
2025-09-30	$34,902,952	272,169	+1.7%	Shares	Sole	2025-11-06
2025-06-30	$32,374,410	267,535	+20.4%	Shares	Sole	2025-07-30
2025-03-31	$24,762,717	222,127	+3048.1%	Shares	Sole	2025-05-13
2024-09-30	$811,581	7,056	+0.1%	Shares	Sole	2024-11-12
2024-06-30	$750,223	7,047	-2.4%	Shares	Sole	2024-08-14
2024-03-31	$698,390	7,220	-0.6%	Shares	Sole	2024-04-23
2023-12-31	$733,244	7,262	+1.8%	Shares	Sole	2024-01-30
2023-09-30	$726,771	7,135	-95.9%	Shares	Sole	2023-11-07
2022-06-30	$14,849,723	175,674	+2500.3%	Shares	Sole	2022-07-20
2020-06-30	$590,069	6,756	-2.8%	Shares	Sole	2020-08-07
2020-03-31	$573,274	6,953	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.